Foreign Filer Report • Jun 9, 2021
Foreign Filer Report
Open in ViewerOpens in native device viewer
_________ false
| ��� �� �� ������������� ��"� | 2 381 |
| X T L BIOPHARMACEUTICALS LTD | |
| Corporation no: 520039470 | 4313 |
| - - - | |
| Israel Securities Authority | Tel Aviv Stock Exchange | C003 ( Public ) | Reported via MAGNA: | 09/06/2021 | ||||||
| www.isa.gov.il | www.tase.co.il | Reference: | 2021-02-098541 | Time of broadcast: 15:25 15:25 |
Other Report or AnnouncementRegulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
| The corporation is a foreign private issuer as defined by U.S. Securities Laws. |
| Attached hereto is a report on | Final Prospectus |
ea142399-424b3_xtlbiopharmaEDGAR2bannerless_isa.pdf
| References of previous documents relating to this matter(the reference does not constitute incorporation by reference): | |
| - - - | |
| Stock Exchange/Market: NASDAQ CM | Date of revision of form structure: 04/05/2021 |
| Address: HaCharoshet st 5 , Ra'anana 43656 Israel , Tel: 09-9557080 , Fax: 09-9519708 | |
| E-mail address: [email protected] Company site: www.xtlbio.com | |
| Previous names of reporting entity: XENOGRAFT TECHNOLOGIES LTD | |
| Name of the Signatory: Kntor Ronen Position of Signatory in the reporting corporation: Attorney/Legal Counsel Name of Employer Company: | |
| Address: abba hillel 12 , ramat gan 5250606 Telephone: 03-6133371 Facsimile: 03-6133372 E-mail: [email protected] 1 | |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.